175 related articles for article (PubMed ID: 24585431)
1. Prevalence and natural history of histologically proven chronic liver disease in a longitudinal cohort of patients with type 1 diabetes.
Harman DJ; Kaye PV; Harris R; Suzuki A; Gazis A; Aithal GP
Hepatology; 2014 Jul; 60(1):158-68. PubMed ID: 24585431
[TBL] [Abstract][Full Text] [Related]
2. Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes.
Fracanzani AL; Valenti L; Bugianesi E; Andreoletti M; Colli A; Vanni E; Bertelli C; Fatta E; Bignamini D; Marchesini G; Fargion S
Hepatology; 2008 Sep; 48(3):792-8. PubMed ID: 18752331
[TBL] [Abstract][Full Text] [Related]
3. Increased risk of cirrhosis and its decompensation in chronic hepatitis B patients with newly diagnosed diabetes: a nationwide cohort study.
Huang YW; Wang TC; Lin SC; Chang HY; Chen DS; Hu JT; Yang SS; Kao JH
Clin Infect Dis; 2013 Dec; 57(12):1695-702. PubMed ID: 24051864
[TBL] [Abstract][Full Text] [Related]
4. [Prevalence of diabetes, antidiabetic treatment and chronic diabetic complications reported by general practitioners].
Fabian W; Majkowska L; Stefański A; Moleda P
Przegl Lek; 2005; 62(4):201-5. PubMed ID: 16229234
[TBL] [Abstract][Full Text] [Related]
5. Diabetes mellitus at the time of diagnosis of cirrhosis is associated with higher incidence of spontaneous bacterial peritonitis, but not with increased mortality.
Wlazlo N; van Greevenbroek MM; Curvers J; Schoon EJ; Friederich P; Twisk JW; Bravenboer B; Stehouwer CD
Clin Sci (Lond); 2013 Oct; 125(7):341-8. PubMed ID: 23566037
[TBL] [Abstract][Full Text] [Related]
6. Insulin resistance and diabetes increase fibrosis in the liver of patients with genotype 1 HCV infection.
Petta S; Cammà C; Di Marco V; Alessi N; Cabibi D; Caldarella R; Licata A; Massenti F; Tarantino G; Marchesini G; Craxì A
Am J Gastroenterol; 2008 May; 103(5):1136-44. PubMed ID: 18477344
[TBL] [Abstract][Full Text] [Related]
7. Etiologic types of end-stage chronic liver disease in adults: analysis of prevalence and their temporal changes from a study on native liver explants.
Nayak NC; Jain D; Vasdev N; Gulwani H; Saigal S; Soin A
Eur J Gastroenterol Hepatol; 2012 Oct; 24(10):1199-208. PubMed ID: 22751227
[TBL] [Abstract][Full Text] [Related]
8. Association between comorbidities and dementia in diabetes mellitus patients: population-based retrospective cohort study.
Kuo SC; Lai SW; Hung HC; Muo CH; Hung SC; Liu LL; Chang CW; Hwu YJ; Chen SL; Sung FC
J Diabetes Complications; 2015; 29(8):1071-6. PubMed ID: 26233574
[TBL] [Abstract][Full Text] [Related]
9. Recurrent disease following liver transplantation for nonalcoholic steatohepatitis cirrhosis.
Malik SM; Devera ME; Fontes P; Shaikh O; Sasatomi E; Ahmad J
Liver Transpl; 2009 Dec; 15(12):1843-51. PubMed ID: 19938117
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and incidence of Type 2 diabetes and its complications 1996-2003--estimates from a Swedish population-based study.
Ringborg A; Lindgren P; Martinell M; Yin DD; Schön S; Stålhammar J
Diabet Med; 2008 Oct; 25(10):1178-86. PubMed ID: 19046196
[TBL] [Abstract][Full Text] [Related]
11. Type 2 diabetes mellitus and chronic hepatitis C: which is worse? Results of a long-term retrospective cohort study.
Giordanino C; Ceretto S; Bo S; Smedile A; Ciancio A; Bugianesi E; Pellicano R; Fagoonee S; Versino E; Costa G; Arese D; Sacco M; Rizzetto M; Saracco G
Dig Liver Dis; 2012 May; 44(5):406-12. PubMed ID: 22245505
[TBL] [Abstract][Full Text] [Related]
12. Not only type 2 diabetes but also prediabetes is associated with portal inflammation and fibrosis in patients with non-alcoholic fatty liver disease.
Yilmaz Y; Senates E; Yesil A; Ergelen R; Colak Y
J Diabetes Complications; 2014; 28(3):328-31. PubMed ID: 24602757
[TBL] [Abstract][Full Text] [Related]
13. Natural history of nonalcoholic steatohepatitis: a longitudinal study of repeat liver biopsies.
Fassio E; Alvarez E; Domínguez N; Landeira G; Longo C
Hepatology; 2004 Oct; 40(4):820-6. PubMed ID: 15382171
[TBL] [Abstract][Full Text] [Related]
14. Review article: type 2 diabetes and chronic liver disease in the Verona diabetes study.
Trombetta M; Spiazzi G; Zoppini G; Muggeo M
Aliment Pharmacol Ther; 2005 Nov; 22 Suppl 2():24-7. PubMed ID: 16225467
[TBL] [Abstract][Full Text] [Related]
15. Clinical and histological features of nonalcoholic steatohepatitis in Iranian patients.
Bahrami H; Daryani NE; Mirmomen S; Kamangar F; Haghpanah B; Djalili M
BMC Gastroenterol; 2003 Oct; 3():27. PubMed ID: 14561231
[TBL] [Abstract][Full Text] [Related]
16. Steatosis in chronic hepatitis C: relative contributions of obesity, diabetes mellitus, and alcohol.
Monto A; Alonzo J; Watson JJ; Grunfeld C; Wright TL
Hepatology; 2002 Sep; 36(3):729-36. PubMed ID: 12198667
[TBL] [Abstract][Full Text] [Related]
17. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis.
Angulo P; Keach JC; Batts KP; Lindor KD
Hepatology; 1999 Dec; 30(6):1356-62. PubMed ID: 10573511
[TBL] [Abstract][Full Text] [Related]
18. Clinical manifestations and treatment options in patients with cirrhosis and diabetes mellitus.
Gundling F; Seidl H; Strassen I; Haller B; Siegmund T; Umgelter A; Pehl C; Schepp W; Schumm-Draeger PM
Digestion; 2013; 87(2):75-84. PubMed ID: 23306648
[TBL] [Abstract][Full Text] [Related]
19. Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease.
Caldwell SH; Oelsner DH; Iezzoni JC; Hespenheide EE; Battle EH; Driscoll CJ
Hepatology; 1999 Mar; 29(3):664-9. PubMed ID: 10051466
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of diabetic complications in fibrocalculous pancreatic diabetic patients and type 2 diabetic patients: a cross-sectional comparative study.
Kanta Barman K; Padmanabhan M; Premalatha G; Deepa R; Rema M; Mohan V
J Diabetes Complications; 2004; 18(5):264-70. PubMed ID: 15337499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
